Source: Breathe, 15 (4) 350; 10.1183/20734735.0256-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Thomas Jones. Initial inhaler choice in COPD: real-world evidence. Breathe, 15 (4) 350; 10.1183/20734735.0256-2019

Member's Comments

No comment yet.

Related content which might interest you: Investigating inhaler technique in patients with COPD using different aids Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Handling of inhalers by COPD patients in actual clinical practice Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020 Poor inhaler technique revealed by investigating different aids in patients with COPD Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Comparing asthma and COPD inhaler devices in real life clinical practice in the UK: differences in training requirements and preference Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence Year: 2017 COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique? Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 How can we improve patient use of inhaler devices in COPD? Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 How does the Novolizer fit into the choice of inhaler? Source: Annual Congress 2005 - Asthma management - important issues Year: 2005 Breath activated inhaler usage and impact on rescue medication usage in patients with an asthma diagnosis: a prescribing claims study of 2823 patients using a CFC - pMDI and a breath-actuated device Source: Eur Respir J 2001; 18: Suppl. 33, 71s Year: 2001 Evaluation of adherence of patients with asthma to treatment by single combination inhaler Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006 Comparative in vitro performance of the new drug aclidinium in a novel multidose dry powder inhaler Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Investigating the percentage of patients with COPD who could benefit from a change in inhaler Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 The importance of inhaler technique education in asthma and COPD: a long-term follow-up Source: International Congress 2019 – Medical education Year: 2019 Improving awareness of correct inhaler techniques through an inhaler reference guide Source: International Congress 2016 – Abstracts in medical education, the web and the internet Year: 2016 Importance of inhaler device use status in the control of asthma and COPD: a real life study. Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Preference of the inhaler device and assessment of the technique among the asthmatic and COPD patients Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 An electronic patient decision aid comparing as-needed budesonide-formoterol combination to regular use of inhaled corticosteroid (ICS) in mild asthma: a rapid-cycle design study Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 Description of the UK’s asthma and COPD inhaler use Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Comparison of asthma and COPD patients' perception of appropriate metered-dose inhaler technique with a questionnaire and supervision based reference standard Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Eliminating in-vitro drug-drug interactions in dual and triple fixed-dose combination therapies using a novel cosuspension metered dose inhaler platform Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013